老年患者住院相关残疾的危险因素:系统性审查和元分析
Xiaonan Hao1, Huijing Zhang1, Xinyi Zhao1
1School of Nursing, Jilin University, 965 Xinjiang street, Changchun 130021, China.
Ageing research reviews
|September 27, 2024
概括
住院相关残疾 (HAD) 对老年人产生重大影响. 关键的危险因素包括晚年,并发病,痴呆,虚弱和不活动,为预防策略提供信息.
科学领域:
- 老年学是指老年学的学科.
- 老年医学 老年医学
- 康复医学 康复医学 康复医学
背景情况:
- 住院相关残疾 (HAD) 是老年患者的主要限制.
- 目前对HAD.有有限的管理选择.
- 识别风险因素对于制定预防计划至关重要.
研究的目的:
- 在老年患者中识别和量化HAD的风险因素.
- 为HAD预防计划提供证据,专注于风险因素管理.
- 为医院住院前和住院期间预防HAD的战略提供信息.
主要方法:
- 对横截面和队列研究的系统审查.
- 在 2024 年 3 月搜索了 MEDLINE,Embase,PsycINFO,CINAHL 和 PubMed.
- 包括使用多变量分析来检查HAD风险因素的研究.
主要成果:
- 21项研究在查883.3后符合纳入标准.
- 对HAD的显著风险因素包括晚年,女性性别,高加索族裔,并发症,更好的基线ADL,痴呆症和更长的住院时间.
- 虚弱,身体功能不佳,不移动和妄想是HAD的确诊危险因素.
结论:
- 本综述综合了有关老年人HAD风险因素的证据.
- 这些发现指导了HAD预防策略的制定.
- 有证据支持在住院前和住院期间针对已确定的风险因素的干预措施.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Drug Dosing: Geriatric Patients
358
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
358
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
346
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
346
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
321
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
321
Pharmacodynamics in Geriatric Patients: Effects of Age
325
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
325
Drug Toxicity: Risk factors
184
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
184


